Boyun Yang Hanxiao Yu Minyue Jia Wo Yao Ran Diao Bohui Li Yongfang Wang Ting Li Liuya Ge Huiying Wang
10.3389/fimmu.2022.1084879
Front Immunol
2022 Dec 14;13:1084879.
kimura disease anti-il-4/il-13 anti-ige biologics dupilimab treatment
CC BY
https://pubmed.ncbi.nlm.nih.gov/36591252/
Biological Products / therapeutic use Kimura Disease / drug therapy
Biological Products / therapeutic use Kimura Disease / drug therapy Review Case Reports Research Support, Non-U.S. Gov't Antibodies, Monoclonal, Humanized / therapeutic use Humans Immunosuppressive Agents Male Middle Aged Omalizumab / therapeutic use dupilumab Antibodies, Monoclonal, Humanized Omalizumab Immunosuppressive Agents Biological Products
PMC9794988
36591252
Successful treatment of dupilumab in Kimura disease independent of IgE: A case report with literature review
2022